Personalised Cardiology - The Future Of Heart Health BW Healthcare
See original here:
Personalised Cardiology - The Future Of Heart Health - BW Healthcare
Category Archives: Cardiology
Sulphur Springs cardiology services to expand with creation of Heart and Vascular Institute – The Sulphur Springs News-Telegram
CHRISTUS Health Public Relations Coleman.Swierc@chrsistushealth. org
CHRISTUS Health is expanding its cardiology program to the greater Hopkins County community with the creation of the CHRISTUS Heart & Vascular Institute Sulphur Springs.
On June 3, CHRISTUS Heart & Vascular Institute cardiologists will start seeing patients at the newly formed clinic on the campus of CHRISTUS Mother Frances Hospital Sulphur Springs, with access to the hospital emergency room, non-invasive cardiovascular services, and the cardiac cath lab.
This is a major step forward for us in our efforts to expand our high-quality cardiology services for our community, said Paul Harvey, president of CHRISTUS Mother Frances Hospital Sulphur Springs. Our community deserves to have excellent heart care close to home, and we are committed to providing that.
CHRISTUS will hold a blessing ceremony for the new clinic, located at 100 Medical Drive in Sulphur Springs, on Monday, June 3 at 11 a.m. with a community grand opening event to follow in the summer.
The CHRISTUS Heart & Vascular Institute Sulphur Springs will work in close coordination with the teams at the CHRISTUS Heart & Vascular Institute and Louis and Peaches Owen Heart Hospital in Tyler, which has earned the National Distinction of Excellence as a HeartCARE Center four times from the American College of Cardiology, has earned a Comprehensive Cardiac Care Center certification from the American Heart Association and the Joint Commission, while maintaining a top-ranked heart surgery program as designated by the Society of Thoracic Surgeons.
The institute will be part of the CHRISTUS Trinity Clinic team that currently employs more than 100 cardiologists, electrophysiologists, surgeons, and advanced practice clinicians in the Northeast Texas region.
We remain steadfast in our mission of extending the healing ministry of Jesus Christ and are blessed to provide Sulphur Springs and the surrounding areas the cardiovascular care they deserve, said Deb Chelette, vice president of cardiovascular services, CHRISTUS Northeast Texas. Residents in Northeast Texas are accustomed to receiving innovative, quality heart care from CHRISTUS and we are looking forward to making more strides in cardiovascular care to ensure that your heart is in good health.
Dr. Fagg Sanford, chair of the CHRISTUS Heart and Vascular Institute - Tyler added, The CHRISTUS Heart and Vascular Institute brings accessible, seamless, and highest quality heart and vascular care to Sulphur Springs, integrating the new CHRISTUS Trinity Clinic Cardiology - Sulphur Springs and the well-established CHRISTUS Mother Frances Hospital - Sulphur Springs with the entire Northeast Texas CHRISTUS team. The power of this integrated model of dedicated clinicians and highest quality hospitals, linked by the common Epic electronic medical record, cant be overstated.
New and existing patients can call (903) 4388330 to schedule an appointment.
Excerpt from:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology | DAIC – Diagnostic and Interventional Cardiology
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the societys new partnership with Informa Markets, key topics being covered at HIMSS24, AIs impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
Last August, Informa Markets and HIMSSannounced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the worlds largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
At HIMSS2024, with this new collaboration comes new features, including:
Find more HIMSS24 conference coverage here
HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation
Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
The rest is here:
World Heart Federation honors cardiologist Valentin Fuster for lifetime of service – Cardiovascular Business
Fuster has held a long list of titles over the course of his careerincluding president of the World Heart Federationand been recognized for his impact on cardiovascular health by many organizations, including the American Heart Association, the American College of Cardiology, the European Society of Cardiology and the Interamerican Society of Cardiology.
One of his biggest projects in recent years has been leading research into the safety and effectiveness of polypills that include three separate medications. The SECURE study, which included data from nearly 2,500 patients, found that taking polypills following a myocardial infarction (MI) was associated with a 24% lower risk of cardiovascular death, nonfatal MI, nonfatal stroke or emergency coronary revascularization compared to usual care.
The World Heart Federation is a global healthcare organization focused on reducing cardiovascular disease. It has relationships with medical societies and patient advocacy groups in more than 100 countries throughout the world. Click here for additional details on Fusters honor and other individuals who were celebrated by the World Heart Federation for going above and beyond in their mission to fight cardiovascular disease and promote healthy hearts in their communities and beyond.
Continue reading here:
Cardiologists ID signs of widespread heart disease in ancient mummies – Cardiovascular Business
Mummies included in the study came from cultures spanning more than 4,000 years. The estimated mean age was 40 years oldyoung by modern standards, but much older for the time. The researchers highlighted what todays patients should take from these ancient samples.
This study indicates modern cardiovascular risk factorssuch as smoking, sedentary lifestyle, and poor dieton top of the underlying, inherent risk natural to the human aging process may increase the extent and impact of atherosclerosis, Thompson said. This is why it is all the more important to control the risk factors we can control.
The group also noted that it was very conservative with its estimates due to the risk that findings would be impacted by distorted tissue samples. In addition, a majority of the mummies only had a limited number of vascular beds that were able to be included in the analysis.
Even with these limitations, however, the authors believe these findings show that atherosclerosis has been prevalent for much longer than many cardiologists may realize.
Thompson has been involved in several past CT studies of ancient mummies from around the word.
Click here to read the full study in European Heart Journal, a publication of the European Society of Cardiology.
See the original post:
Cardiologists ID signs of widespread heart disease in ancient mummies - Cardiovascular Business
Cardiology Adventist Today – Adventist Today
30 May 2024 | Adventist Health in Glendale One of First to Implant Heart Device On May 16, interventional cardiology specialists at Adventist Health Glendale in Glendale, California, United States, successfully performed their first TriClip procedures using the Abbott TriClip transcatheter edge-to-edge repair (TEER) system. Full story at the Adventist Review website. Antillean Adventist University []
Read more here:
Study Led by Saint Luke’s Mid America Heart Institute Finds Widespread Evidence of Heart Disease in Ancient … – Saint Luke’s Health System
KANSAS CITY, Mo. Heart disease is usually thought of as a disease of modern times, but a new study of ancient mummies expands evidence that humans have suffered from the condition for thousands of years across the globe.
The findings of the Global HORUS Study, published in the European Heart Journal, suggests humans have an innate predisposition to atherosclerosis, or a build-up of plaque in the arteries that can lead to heart attack and stroke.
Researchers analyzed the CT scans from 237 adult mummies from around the world and found definite or probable atherosclerosis, marked by calcifications in the artery walls, in more than 37%.
The mummies were from seven different cultures spanning over 4,000 years and included ancient Egyptian, lowland ancient Peruvians, ancient highland Andean Bolivians, 19th century Aleutian Islander hunter-gatherers, 16th century Greenlandic Inuits, ancestral Puebloan, and Middle-Ages Gobi Desert pastoralists.
While previous research has found atherosclerosis in ancient mummies, the HORUS Study is the largest systematic study of the condition in ancient human remains across multiple eras and geographies.
We found atherosclerosis in all time periodsdating before 2,500 BCEin both men and women, in all seven cultures that were studied, and in both elites and non-elites, said Randall Thompson, MD, lead author of the study and cardiologist at Saint Lukes Mid America Heart Institute. This further supports our previous observation that it is not just a modern condition caused by our modern lifestyles.
Researchers note that although the frequency of the disease in the group studied may be surprising, especially since the estimated mean age of 40 is young by todays standardsmost cases were consistent with early disease that is often found incidentally on CT scans of modern patients.
This study indicates modern cardiovascular risk factorssuch as smoking, sedentary lifestyle, and poor dieton top of the underlying, inherent risk natural to the human aging process may increase the extent and impact of atherosclerosis, Dr. Thompson said. This is why it is all the more important to control the risk factors we can control.
Pointing out the studys limitations, including a varying degree of preservation and the impact of the mummification process on tissue, researchers note they were very conservative in assessing the presence of atherosclerosis while analyzing the scans.
Read the full article Atherosclerosis in Ancient Mummified Humans: The Global HORUS Study in the European Heart Journal.
About Saint Lukes Mid America Heart Institute Saint Lukes Mid America Heart Institute is part of Saint Lukes Health System, which serves the West Region of BJC Health System, one of the largest nonprofit health care organizations in the United States. The Heart Institute, a teaching affiliate of the University of Missouri-Kansas City School of Medicine, is one of the distinguished cardiovascular programs in the country. Its legacy of innovation began more than 40 years ago when it opened as the nations first freestanding heart hospital. Since then, the Heart Institute has earned a global reputation for excellence in the treatment of heart disease, including interventional cardiology, cardiovascular surgery, imaging, heart failure, transplant, heart disease prevention, cardiometabolic disease, womens heart disease, electrophysiology, outcomes research, and health economics. Saint Lukes Mid America Heart Institute cardiologists offer personalized cardio-oncology care, where our experts diagnose and treat heart conditions in patients who have been or are being treated for cancer.
With more than 100 full-time, board-certified cardiovascular specialists on staff, Saint Lukes Mid America Heart Institute offers one of the country's largest heart failure and heart transplant programs, has the largest experience with transcatheter aortic valve replacement in the Midwest, and is a global teaching site for the newest approaches in coronary revascularization. The Heart Institute's cardiovascular research program encompasses clinical areas as well as centers of excellence and core laboratories. It continues to serve as one of the four Analytic Centers, along with Duke, Harvard, and Yale, for the American College of Cardiology's National Cardiovascular Data Registry.
Saint Lukes Mid America Heart Institute is ranked 47th in the nation for Cardiology, Heart & Vascular Surgery by U.S. News & World Report and is the third hospital in the U.S. to achieve the Comprehensive Cardiac Center certification from The Joint Commission.
Media Contact
Lindsey Stich,lstich@saintlukeskc.org
Here is the original post:
Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active – Diagnostic and Interventional Cardiology
May 28, 2024 Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).1
Patients who practiced yoga on top of taking their medications felt better, were able to do more, and had stronger hearts than those who only took drugs for their heart failure, said study author Dr. Ajit Singh of the Indian Council of Medical Research (ICMR), Manipal Academy of Higher Education, India. The findings suggest that yoga can be a beneficial complementary therapy in patients with heart failure.
Heart Failure affects vast numbers of people more than 64 million globally2 and can have devastating impacts on quality of life, with patients feeling tired and breathless, and being unable to participate in their usual activities. While previous studies have shown the short-term benefits of yoga in patients with heart failure,3,4this study provides new information about the long-term effects.
The study enrolled patients aged 30 to 70 years with heart failure from the cardiology outpatient department of Kasturba Hospital in Manipal, India. All participants had undergone a cardiac procedure within the past six months to one year and were taking guideline-recommended heart failure medications. Patients with severe symptoms were excluded.5
The study included 85 patients. The average age was 49 years and 70 (82%) were men. In a non-randomized fashion, 40 patients were assigned to the yoga group and 45 patients were allocated to the control group. All participants continued taking guideline-recommended heart failure medications throughout the study.
Experienced faculty in the hospitals Department of Yoga demonstrated pranayama (yogic breathwork), meditation, and relaxation techniques to patients in the yoga group.6Participants were supervised for one week and then advised to continue self-administered yoga at home once a week for 50 minutes. Patients spoke to an instructor after each home session to check progress.
At baseline, six months, and one year, the researchers assessed heart structure and function in the yoga and control groups using echocardiography. The measurements included the ability of the heart to pump blood (left ventricular ejection fraction), and assessment of right ventricular function. The researchers also examined blood pressure, heart rate, body weight, and body mass index. Symptom burden and the ability to do ordinary activities such as walking and climbing stairs were assessed using the New York Heart Association classification system.
Compared to the control group, the yoga group demonstrated significantly greater improvements in all measurements at six months and one year relative to baseline.
Dr. Singh said: Patients who did yoga had healthier hearts and were more able to carry out ordinary activities such as walking and climbing stairs than those who only took medications. Patients with heart failure should speak to their doctor before starting yoga and should then receive training from an experienced instructor. Prescribed medications should be continued as before. Yoga may be unsuitable for heart failure patients with severe symptoms, who were excluded from our study.
For more information: http://www.escardio.org
Find more ESC24 conference coverage here
1The abstract Impact of yoga therapy on long-term outcomes in heart failure patients using functional and echocardiographic parameters will be presented during the session Chronic heart failure - treatment 16 which takes place on 12 May 2024 at 16:00 WEST at Moderated ePosters 2.
2Savarese G, Becher PM, Lund LH,et al. Global burden of heart failure: a comprehensive and updated review of epidemiology.Cardiovasc Res. 2023;118(17):3272-3287.
3Pullen PR, Thompson WR, Benardot D,et al. Benefits of yoga for African American heart failure patients.Med Sci Sports Exerc. 2010;42(4):651657.
4Pullen PR, Nagamia SH, Mehta PK,et al. Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure.J Card Fail. 2008;14(5):407413.
5The study enrolled patients with New York Heart Classification III or less. Those with class IV were excluded.
6Instructions were given on pranayama techniques, including: 1) ujjayi pranayama (5 minutes), which involves breathing with both nostrils and is sometimes called ocean breath; 2) anuloma viloma pranayama (5 minutes), meaning alternate breathing with each nostril; 3) shitali pranayama (5 minutes), which involves inhaling through a curled tongue and exhaling through the nose; 4) sitkari pranayama (5 minutes), which involves breathing through the mouth with a hissing sound; and 5) bhramari pranayama (5 minutes), a humming breath practice known as bee breath. After the pranayama techniques, participants were asked to do soham meditation (10 minutes) involving repetition of the word ohm. Finally, participants performed shavasana, also called corpse pose, in the supine position. Shavasana-1 (5 minutes) involved focusing on the breathing movement, and was followed by shavasana-2 (10 minutes), in which participants relaxed their body part by part.
Read more from the original source:
AI-Powered Ultrasound Device Enhances Cardiac Monitoring for Chemotherapy Patients – Diagnostic and Interventional Cardiology
May 30, 2024 Arecent studypublished in the European Heart Journal highlights the significant enhancements that the Kosmos ultrasound system, developed by EchoNous, brings to cardiac evaluations for chemotherapy patients. This AI-powered device enables even non-expert ultrasound users, such as junior oncologists and nurses, to accurately and swiftly assess left ventricular ejection fraction (LVEF), a crucial indicator of heart health and a critical measure to monitor in patients undergoing chemotherapy treatment.
Dr. Dimitri Dionysopolous, one of the study's authors, highlighted the Kosmoss significant impact: With very little training, oncology staff can accurately measure a patient's heart function in real-time. Our study revealed that the measurement process is very fast, taking less than 10 minutes from start to finish, which could dramatically change how we implement care in practice.
Kosmos, equipped with AI algorithms Trio and Kosmos Auto EF, guides users through the scanning process, making it easier to learn and enabling precise cardiac and abdominal imaging, along with more efficient LVEF calculations. This system, which produces high-quality echocardiographic images at the point of care, is a testament to the potential of AI in healthcare.
This is a tremendous result that fits into many conversations happening around healthcare right now, said Graham Cox, CEO at EchoNous. Healthcare organizations desperately need to enable less trained medical staff to perform ultrasound exams, and this study shows that its feasible with Kosmos and its AI capabilities.
In the study involving 115 patients, cardiologists performed traditional echocardiography and compared it with scans that oncology staff, including senior oncologists, residents, and nurses, performed using the Kosmos ultrasound system. The findings demonstrate that non-ultrasound experts can effectively use Kosmos, achieving diagnostic accuracy between 89 to 94 percent among different operators. These promising results suggest a future where Kosmos could be widely used by oncology staff, leading to faster clinical workflows and enhanced care for cancer patients.
EchoNous will be showcasing the potential of Kosmos at the 2024 ASCO Annual Meeting from May 31 to June 4. Attendees are invited to visit our booth to learn more and chat with us.
For more information:www.echonous.com
UltraSight and EchoNous Partner to Enable More Accessible Cardiac Ultrasound for Patients
FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler
Go here to see the original:
Valentin Fuster, MD, PhD, Receives Prestigious Award From World Heart Federation – Mount Sinai
The World Heart Federation (WHF) is honoring Valentin Fuster, MD, PhD, President ofMount Sinai Fuster Heart Hospitaland Physician-in-Chief of The Mount Sinai Hospital, with its Lifetime Achievement Award for 2024. This top honor recognizes his remarkable contributions to the WHF mission, and to the entire cardiovascular disease community for his dedication to combating this disease worldwide.
The WHF will present Dr. Fuster with this award on Saturday, May 25, during the World Heart Summit in Geneva, Switzerland.
I am proud of this award, particularly because it represents Mount Sinais worldwide scientific contributions and dedication to advancements in the cardiovascular field, says Dr. Fuster.
Dr. Fuster is a pre-eminent leader in cardiovascular medicine. His contributions to the field, and to prevention and treatment of heart disease globally, are unparalleled. Dr. Fuster was named Director of the Cardiovascular Institute at Mount Sinai in 1994, became Director of Mount Sinai Heart at its establishment in 2006, and held that position until the end of 2022. He built what is now known as Mount Sinai Fuster Heart Hospital into one of the worlds leading centers for cardiovascular care, cardiac surgery, and advanced research. Dr. Fuster is also General Director of the Spanish National Center for Cardiovascular Research (CNIC).
Dr. Fuster also helped develop a cardiovascular polypilla single pill that includes three medications typically taken separatelythat is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack. Dr. Fuster and his team showed that the polypill reduces cardiovascular mortality by 33 percent in this population. This medication was recently included by the World Health Organization in itsList of Essential Medicinesand is pending Food and Drug Administration approval in the United States.
His research into the origin of cardiovascular events, which has contributed to improved treatment of heart attack patients, was recognized in 1996 by the Prince of Asturias Award for Technical and Scientific Research, the highest international award given by Dr. Fusters native Spain. In June 2011 he was awarded the Grand Prix Scientifique of the Institute of France for his translational research into atherothrombotic disease. Recently, he was named a Prince Mahidol Award Laureate in Thailand for his lifelong contribution to the field of medicine, and in 2022, the American College of Cardiology instituted the Valentin Fuster Award in Science and Innovation, which will be given to a single physician annually for the next 14 years.
Dr. Fuster has also received the highest awards for research from the four leading cardiovascular organizations: the American Heart Association (Gold Medal and Research Achievement Award), the American College of Cardiology (Living Legend and Life Achievement Award), the European Society of Cardiology (Gold Medal), and the Interamerican Society of Cardiology (Research Achievement Award). In May 2014, King Juan Carlos I of Spain granted Dr. Fuster the title of Marquis for his "outstanding and unceasing research efforts and his educational outreach work."
Mount Sinai is a World Leader in Cardiology and Heart Surgery
Mount Sinai Fuster Heart Hospital at The Mount Sinai Hospital ranks No. 1 in New York and No. 4 globally according to Newsweeks The Worlds Best Specialized Hospitals. It also ranks No. 1 in New York for cardiology, heart, and vascular surgery, according to U.S. News & World Report.
It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweeks The Worlds Best Smart Hospitals and by U.S. News & World Report's Best Hospitals and Best Childrens Hospitals. The Mount Sinai Hospital is on the U.S. News & World Report's Best Hospitals Honor Roll for 2023-2024.
For more information, visithttps://www.mountsinai.orgor find Mount Sinai onFacebook,TwitterandYouTube.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our timediscovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweeks The Worlds Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals and by U.S. News & World Report's Best Hospitals and Best Childrens Hospitals. The Mount Sinai Hospital is on the U.S. News & World Report Best Hospitals Honor Roll for 2023-2024.
For more information, visithttps://www.mountsinai.orgor find Mount Sinai onFacebook,TwitterandYouTube.
See more here:
Valentin Fuster, MD, PhD, Receives Prestigious Award From World Heart Federation - Mount Sinai